retatrutide type 2 diabetes phase 2 trial 2024 The Effect of on Kidney Parameters in Participants With Mellitus and/or Obesity The MariTide phase 2 trial
Description
Individual results vary based on metabolism, adherence, and genetic factors that influence GLP-1 receptor sensitivity
Everything is going up, so I locked one thing down
GLP-1 medications reduce appetite and slow stomach emptying, which changes how your body tolerates fatty foods like cheese
And it's like, that's not exactly what we should be eating. Mark Hyman
